Sector Update: Shares Mixed Pre-Market; Gilead Lifts on Phase 3 Results for Hepatitis C Treatment


Top Healthcare stocks:

JNJ: -0.37%

PFE: -0.14%

ABT: +0.08%

MRK: flat

AMGN: flat

Healthcare shares were mixed in pre-market trade on Monday.

In healthcare stocks news, Allergan ( AGN ) said it still considers Valeant Pharmaceutical International's (VRX, VRX.TO) business model to be unsustainable and that the $72-per share and 0.83 Valeant stock offer creates "significant risks and uncertainties for Allergan shareholders."

Allergan said Valeant's business model relies on "serial acquisitions and cost reductions, as opposed to top-line revenue growth and operational excellence."

And, Gilead Sciences, Inc. ( GILD ) shares were up slightly after it reported topline results from a Phase 3 clinical trial in Japan evaluating the investigational once-daily fixed-dose combination for the treatment of genotype 1 chronic hepatitis C virus infection.

GILD trades in a 52-week range of $46.70 to $84.88.

Also, Response Genetics ( RGDX ) which is focused on the development and sale of molecular diagnostic tests that help guide cancer therapy selection, announced new testing capabilities to advance cancer immunotherapy clinical development.

RGDX was steady pre-market, having closed up 2.8% at $0.91.

Finally, Cephid ( CPHD ) said early Monday it has released Xpert Carba-R, an on-demand molecular test for rapid and accurate detection of carbapenemase-producing Gram-negative bacteria, to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities

Referenced Stocks: AGN , GILD , RGDX , CPHD

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

The Pumpkin Carvers
The Pumpkin Carvers                 



Most Active by Volume

  • $97.19 ▲ 2.61%
  • $71.29 ▲ 2.92%
  • $44.87 ▲ 0.09%
  • $28.75 ▲ 0.81%
    $15.52 unch
  • $3.46 ▼ 0.57%
  • $22.43 ▼ 9.63%
  • $34.71 ▲ 3.30%
As of 7/23/2014, 04:04 PM